Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases
Background Patients with inflammatory bowel diseases (IBD) have an increased risk of clostridium difficile infection (CDI). Cathelicidins are anti-microbial peptides that attenuate colitis and inhibit the effect of clostridial toxins. Plasma calcifediol [25(OH)D] stimulates production of cathelicidi...
Main Authors: | Ananthakrishnan, A. N. (Author), Cagan, A. (Author), Gainer, V. S. (Author), Cheng, S.-C (Author), Cai, T. (Author), Shaw, S. Y. (Author), Churchill, S. (Author), Karlson, E. W. (Author), Murphy, Shawn N. (Author), Kohane, I. (Author), Liao, K. P. (Author), Szolovits, Peter (Contributor) |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science (Contributor) |
Format: | Article |
Language: | English |
Published: |
Wiley Blackwell,
2016-02-02T13:12:44Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Association Between Reduced Plasma 25-Hydroxy Vitamin D and Increased Risk of Cancer in Patients With Inflammatory Bowel Diseases
by: Ananthakrishnan, Ashwin N., et al.
Published: (2016) -
Serum Inflammatory Markers and Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases
by: Ananthakrishnan, Ashwin N., et al.
Published: (2016) -
Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease
by: Ananthakrishnan, Ashwin N., et al.
Published: (2016) -
Clostridium difficile in inflammatory bowel disease
by: O V Knyazev, et al.
Published: (2018-11-01) -
Thromboprophylaxis Is Associated With Reduced Post-hospitalization Venous Thromboembolic Events in Patients With Inflammatory Bowel Diseases
by: Ananthakrishnan, Ashwin N., et al.
Published: (2016)